The Inflation Reduction Act in numbers: estimating the impact of implementing Medicare drug pricing policies on the US healthcare ecosystem

Research firm Vital Transformation has recently released two reports modeling the impact of emerging government-mandated drug pricing policies in Medicare stemming from the Inflation Reduction Act (IRA) on medical innovation and jobs. Here, we summarize the results of these reports and what this means for healthcare research and access to medicines.  Background: The Inflation Reduction Act in numbers Authorized in August 2022, the IRA is a landmark piece of legislation in the US that includes several provisions aimed at lowering prescription drug prices, expanding access to health insurance, and improving the quality of care. For the first time, Medicare will...